Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling

Jennifer D. Young, Vincenzo Abbate, Cinzia Imberti, Levente K. Meszaros, Michelle T. Ma, Samantha Y.A. Terry, Robert C. Hider, Greg E. Mullen and Philip J. Blower
Journal of Nuclear Medicine August 2017, 58 (8) 1270-1277; DOI: https://doi.org/10.2967/jnumed.117.191882
Jennifer D. Young
1Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincenzo Abbate
2Institute of Pharmaceutical Science, King's College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cinzia Imberti
1Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Levente K. Meszaros
1Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle T. Ma
1Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Y.A. Terry
1Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert C. Hider
2Institute of Pharmaceutical Science, King's College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg E. Mullen
1Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip J. Blower
1Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 8 1270-1277
DOI 
https://doi.org/10.2967/jnumed.117.191882
PubMed 
28408532

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 21, 2017
  • Accepted for publication April 3, 2017
  • Published online August 1, 2017.

Article Versions

  • previous version (April 13, 2017 - 04:49).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Jennifer D. Young1,
  2. Vincenzo Abbate2,
  3. Cinzia Imberti1,
  4. Levente K. Meszaros1,
  5. Michelle T. Ma1,
  6. Samantha Y.A. Terry1,
  7. Robert C. Hider2,
  8. Greg E. Mullen1 and
  9. Philip J. Blower1
  1. 1Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; and
  2. 2Institute of Pharmaceutical Science, King's College London, London, United Kingdom
  1. For correspondence contact: Philip J. Blower, Division of Imaging Sciences and Biomedical Engineering, King’s College London, St Thomas’ Hospital, London, SE17EH, U.K. E-mail: Philip.Blower{at}kcl.ac.uk
View Full Text

Statistics from Altmetric.com

Cited By...

  • 75 Citations
  • 79 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
    Thomas I. Kostelnik, Chris Orvig
    Chemical Reviews 2019 119 2
  • Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling
    Maria Iris Tsionou, Caroline E. Knapp, Calum A. Foley, Catherine R. Munteanu, Andrew Cakebread, Cinzia Imberti, Thomas R. Eykyn, Jennifer D. Young, Brett M. Paterson, Philip J. Blower, Michelle T. Ma
    RSC Adv. 2017 7 78
  • Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
    Nat Lenzo, Danielle Meyrick, J. Turner
    Diagnostics 2018 8 1
  • Theranostic radiopharmaceuticals: established agents in current use
    James R Ballinger
    The British Journal of Radiology 2018 91 1091
  • Hydroxypyridinone Journey into Metal Chelation
    Agostino Cilibrizzi, Vincenzo Abbate, Yu-Lin Chen, Yongmin Ma, Tao Zhou, Robert C. Hider
    Chemical Reviews 2018 118 16
  • Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of 68Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer
    Michael S. Hofman, Peter Eu, Price Jackson, Emily Hong, David Binns, Amir Iravani, Declan Murphy, Catherine Mitchell, Shankar Siva, Rodney J. Hicks, Jennifer D. Young, Philip J. Blower, Gregory E. Mullen
    Journal of Nuclear Medicine 2018 59 4
  • Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals
    Mauricio Morais, Michelle T. Ma
    Drug Discovery Today: Technologies 2018 30
  • 18F-AlF Labeled Peptide and Protein Conjugates as Positron Emission Tomography Imaging Pharmaceuticals
    Krishan Kumar, Arijit Ghosh
    Bioconjugate Chemistry 2018 29 4
  • The aluminium-[18F]fluoride revolution: simple radiochemistry with a big impact for radiolabelled biomolecules
    Stephen J. Archibald, Louis Allott
    EJNMMI Radiopharmacy and Chemistry 2021 6 1
  • Chelators and metal complex stability for radiopharmaceutical applications
    Nkemakonam C. Okoye, Jakob E. Baumeister, Firouzeh Najafi Khosroshahi, Heather M. Hennkens, Silvia S. Jurisson
    Radiochimica Acta 2019 107 9-11

Article usage

Article usage: May 2017 to May 2025

AbstractFullPdf
Apr 2017548098
May 2017271073
Jun 2017183088
Jul 201796039
Aug 2017113326128
Sep 20172732745
Oct 20172654177
Nov 20171853466
Dec 20171111939
Jan 2018881952
Feb 20186155133
Mar 20181132452
Apr 2018806485
May 2018565546
Jun 2018414340
Jul 2018272834
Aug 2018342930
Sep 2018455555
Oct 2018555364
Nov 2018563775
Dec 2018203023
Jan 2019552445
Feb 2019325938
Mar 2019415249
Apr 2019232233
May 2019303135
Jun 2019192543
Jul 2019422730
Aug 2019212931
Sep 2019232127
Oct 2019346751
Nov 2019302575
Dec 2019201931
Jan 2020271627
Feb 2020302032
Mar 2020372434
Apr 2020331321
May 2020391427
Jun 2020311238
Jul 20201488
Aug 2020192721
Sep 2020251932
Oct 2020382132
Nov 202024652
Dec 2020171925
Jan 2021104837
Feb 2021174641
Mar 2021136851
Apr 2021162944
May 2021105133
Jun 2021144140
Jul 2021235850
Aug 2021144430
Sep 2021115234
Oct 202173139
Nov 20211810151
Dec 2021105039
Jan 2022174034
Feb 2022113224
Mar 202262623
Apr 2022113332
May 202265131
Jun 202273929
Jul 20226329
Aug 2022104649
Sep 202266021
Oct 202282819
Nov 2022814947
Dec 202282813
Jan 202364720
Feb 202369017
Mar 2023126223
Apr 2023122524
May 2023133429
Jun 2023102518
Jul 2023133526
Aug 2023292427
Sep 2023135717
Oct 2023195021
Nov 2023213526
Dec 202317319
Jan 2024244721
Feb 2024275733
Mar 202462748
Apr 2024124328
May 202494223
Jun 202464732
Jul 2024245329
Aug 2024163632
Sep 202463626
Oct 2024104621
Nov 2024102610
Dec 202422916
Jan 2025116347
Feb 2025197722
Mar 202578242
Apr 2025176973
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (8)
Journal of Nuclear Medicine
Vol. 58, Issue 8
August 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling
Jennifer D. Young, Vincenzo Abbate, Cinzia Imberti, Levente K. Meszaros, Michelle T. Ma, Samantha Y.A. Terry, Robert C. Hider, Greg E. Mullen, Philip J. Blower
Journal of Nuclear Medicine Aug 2017, 58 (8) 1270-1277; DOI: 10.2967/jnumed.117.191882

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling
Jennifer D. Young, Vincenzo Abbate, Cinzia Imberti, Levente K. Meszaros, Michelle T. Ma, Samantha Y.A. Terry, Robert C. Hider, Greg E. Mullen, Philip J. Blower
Journal of Nuclear Medicine Aug 2017, 58 (8) 1270-1277; DOI: 10.2967/jnumed.117.191882
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • 68Ga-Bisphosphonates for the Imaging of Extraosseous Calcification by Positron Emission Tomography
  • A Phase II, Open-Label Study to Assess Safety and Management Change Using 68Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study
  • Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of 68Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer
  • Google Scholar

More in this TOC Section

Theranostics

  • Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Show more Theranostics

Basic

  • Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
  • Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
  • Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Show more Basic

Similar Articles

Keywords

  • PSMA receptor
  • PET imaging
  • gallium chelators
  • prostate cancer
  • radiopharmaceutical kit
SNMMI

© 2025 SNMMI

Powered by HighWire